SCHEMBL2173099

SCHEMBL2173099

CC(C)(C)[Si](C)(C)OC1CCNc2ccccc21

nearest known ligand 0.34

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.34
BRD4 O60885 1/20 0.31
F12 P00748 6/20 0.31
EHMT2 Q96KQ7 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL983247 1.00 BCHE (0.34) BCHEBRD4F12EHMT2
SCHEMBL4861693 0.92 BCHE (0.33) BCHEBRD4
SCHEMBL6332883 0.82 BACE1 (0.32) BCHE
SCHEMBL13315859 0.76 HTR2C (0.39) BCHEF12
SCHEMBL22056586 0.74 IDO1 (0.53) BCHE
SCHEMBL13573053 0.73 SLC6A2 (0.31)
SCHEMBL4152363 0.72 SSTR4 (0.38)
SCHEMBL1657412 0.71 CCR2 (0.31)
SCHEMBL1659607 0.71 CCR2 (0.31)
SCHEMBL7614191 0.71 CCR2 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107922405-B Compound with ERK kinase inhibitory activity, preparation method and application thereof 中国科学院上海药物研究所 2021-02-19 CN disclosed
WO-2017114510-A1 COMPOUND HAVING ERK KINASE INHIBITORY ACTIVITY, METHOD FOR PREPARATION THEREOF, AND USE THEREOF 中国科学院上海药物研究所 2017-07-06 WO disclosed
EP-1964925-B1 PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE 4-HYDROXY-1,2,3,4 -TETRAHYDROQUINOLINES MITSUBISHI TANABE PHARMA CORP (JP) 2016-03-30 EP disclosed
US-7972836-B2 Method of enzymatic optical resolution of racemic 4-hydroxy-1,2,3,4-tetrahydroquinoline MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-07-05 US disclosed
US-20090269821-A1 Method for Preparing Optically Active 4-Hydroxy-1,2,3,4-Tetrahydroquinoline Compound MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-10-29 US disclosed
EP-1964925-A1 PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE 4-HYDROXY-1,2,3,4 -TETRAHYDROQUINOLINES Mitsubishi Tanabe Pharma Corporation (JP) 2008-09-03 EP disclosed